[1] A. Palmquist, O.M. Omar, M. Esposito, J. Lausmaa, P. Thomsen, Titanium oral implants: surface characteristics, interface biology and clinical outcome, J. R. Soc. Interface 7 Suppl 5 (2010) S515–S527.
[2] L. Linder, T. Albrektsson, P.I. Branemark, H.A. Hansson, B. Ivarsson, U. Jons- son, I. Lundstrom, Electron microscopic analysis of the bone-titanium interface, Acta Orthop. Scand. 54 (1) (1983) 45–52.
[3] C. Johansson, J. Lausmaa, M. Ask, H.A. Hansson, T. Albrektsson, Ultrastructural differences of the interface zone between bone and Ti 6Al 4V or commercially pure titanium, J. Biomed. Eng. 11 (1) (1989) 3–8.
[4] D.E. Steflik, G.R. Parr, A.L. Sisk, P.J. Hanes, F.T. Lake, Electron microscopy of bone response to titanium cylindrical screw-type endosseous dental implants, Int. J. Oral Maxillofac. Implant. 7 (4) (1992) 497–507.
[5] K. Murai, F. Takeshita, Y. Ayukawa, T. Kiyoshima, T. Suetsugu, T. Tanaka, Light and electron microscopic studies of bone-titanium interface in the tibiae of young and mature rats, J. Biomed. Mater. Res. 30 (4) (1996) 523–533.
[6] G. Sundell, C. Dahlin, M. Andersson, M. Thuvander, The bone-implant interface of dental implants in humans on the atomic scale, Acta Biomater. 48 (2017) 445–450.
[7] K. Sugimoto, S. Tsuchiya, M. Omori, R. Matsuda, M. Fujio, K. Kuroda, M. Okido, H. Hibi, Proteomic analysis of bone proteins adsorbed onto the surface of tita- nium dioxide, Biochem. Biophys. Rep. 7 (2016) 316–322.
[8] H.K. Nakamura, F. Butz, L. Saruwatari, T. Ogawa, A role for proteoglycans in mineralized tissue-titanium adhesion, J. Dent. Res. 86 (2) (2007) 147–152.
[9] J. Rnjak-Kovacina, F. Tang, J.M. Whitelock, M.S. Lord, Glycosaminoglycan and proteoglycan-based biomaterials: current trends and future perspectives, Adv. Healthc. Mater. 7 (6) (2018) e1701042.
[10] J.J. Collis, G. Embery, Adsorption of glycosaminoglycans to commercially pure titanium, Biomaterials 13 (8) (1992) 548–552.
[11] H. Nakamura, J. Shim, F. Butz, H. Aita, V. Gupta, T. Ogawa, Glycosaminogly- can degradation reduces mineralized tissue-titanium interfacial strength, J. Biomed. Mater. Res. A 77 (3) (2006) 478–486.
[12] M.M. Klinger, F. Rahemtulla, C.W. Prince, L.C. Lucas, J.E. Lemons, Proteoglycans at the bone-implant interface, Crit. Rev. Oral Biol. Med. 9 (4) (1998) 449–463.
[13] T. Albrektsson, Hard tissue implant interface, Aust. Dent. J. 53 Suppl 1 (2008) S34–S38.
[14] Y. Forster, C. Rentsch, W. Schneiders, R. Bernhardt, J.C. Simon, H. Worch, S. Rammelt, Surface modification of implants in long bone, Biomatter 2 (3) (2012) 149–157.
[15] T. Mikami, H. Kitagawa, Biosynthesis and function of chondroitin sulfate, Biochim. Biophys. Acta 1830 (10) (2013) 4719–4733.
[16] S. Yamauchi, S. Mita, T. Matsubara, M. Fukuta, H. Habuchi, K. Kimata, O. Habuchi, Molecular cloning and expression of chondroitin 4-sulfotrans- ferase, J. Biol. Chem. 275 (12) (2000) 8975–8981.
[17] N. Hiraoka, H. Nakagawa, E. Ong, T.O. Akama, M.N. Fukuda, M. Fukuda, Molec- ular cloning and expression of two distinct human chondroitin 4-O-sulfotrans- ferases that belong to the HNK-1 sulfotransferase gene family, J. Biol. Chem. 275 (26) (2000) 20188–20196.
[18] H.G. Kang, M.R. Evers, G. Xia, J.U. Baenziger, M. Schachner, Molecular cloning and characterization of chondroitin-4-O-sulfotransferase-3. A novel member of the HNK-1 family of sulfotransferases, J. Biol. Chem. 277 (38) (2002) 34766–34772.
[19] M.R. Evers, G. Xia, H.G. Kang, M. Schachner, J.U. Baenziger, Molecular cloning and characterization of a dermatan-specific N-acetylgalactosamine 4-O-sulfo- transferase, J. Biol. Chem. 276 (39) (2001) 36344–36353.
[20] T. Mikami, S. Mizumoto, N. Kago, H. Kitagawa, K. Sugahara, Specificities of three distinct human chondroitin/dermatan N-acetylgalactosamine 4-O-sulfo- transferases demonstrated using partially desulfated dermatan sulfate as an acceptor: implication of differential roles in dermatan sulfate biosynthesis, J. Biol. Chem. 278 (38) (2003) 36115–36127.
[21] M. Kluppel, The roles of chondroitin-4-sulfotransferase-1 in development and disease, Prog. Mol. Biol. Transl. Sci. 93 (2010) 113–132.
[22] A. Uccelli, L. Moretta, V. Pistoia, Mesenchymal stem cells in health and disease, Nat. Rev. Immunol. 8 (9) (2008) 726–736.
[23] M. Li, S. Ikehara, Bone-marrow-derived mesenchymal stem cells for organ re- pair, Stem Cells Int. 2013 (2013) 132642.
[24] D.M. Mosser, J.P. Edwards, Exploring the full spectrum of macrophage activa- tion, Nat. Rev. Immunol. 8 (12) (2008) 958–969.
[25] S. Gordon, P.R. Taylor, Monocyte and macrophage heterogeneity, Nat. Rev. Im- munol. 5 (12) (2005) 953–964.
[26] M. Genin, F. Clement, A. Fattaccioli, M. Raes, C. Michiels, M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide, BMC Cancer 15 (2015) 577.
[27] A. Ruggeri, C. Dell’orbo, D. Quacci, Electron microscopic visualization of pro- teoglycans with Ruthenium Red, Histochem. J. 9 (2) (1977) 249–252.
[28] S. Bian, N. Akyuz, C. Bernreuther, G. Loers, E. Laczynska, I. Jakovcevski, M. Schachner, Dermatan sulfotransferase Chst14/D4st1, but not chondroitin sulfotransferase Chst11/C4st1, regulates proliferation and neurogenesis of neu- ral progenitor cells, J. Cell Sci. 124 (Pt 23) (2011) 4051–4063.
[29] T. Albrektsson, P.I. Branemark, H.A. Hansson, J. Lindstrom, Osseointegrated ti- tanium implants. Requirements for ensuring a long-lasting, direct bone-to-im- plant anchorage in man, Acta Orthop. Scand. 52 (2) (1981) 155–170.
[30] T. Albrektsson, M. Jacobsson, Bone-metal interface in osseointegration, J. Pros- thet. Dent. 57 (5) (1987) 597–607.
[31] D.E. Steflik, A.L. Sisk, G.A. Parr, F.T. Lake, P.J. Hanes, Experimental studies of the implant-tissue interface, J. Oral Implantol. 19 (2) (1993) 90–94 discussion 136-7.
[32] K. Okamatsu, H. Kido, A. Sato, A. Watazu, M. Matsuura, Ultrastructure of the interface between titanium and surrounding tissue in rat tibiae–a comparison study on titanium-coated and -uncoated plastic implants, Clin. Implant Dent. Relat. Res. 9 (2) (2007) 100–111.
[33] T. Douglas, S. Heinemann, C. Mietrach, U. Hempel, S. Bierbaum, D. Scharnwe- ber, H. Worch, Interactions of collagen types I and II with chondroitin sulfates A-C and their effect on osteoblast adhesion, Biomacromolecules 8 (4) (2007) 1085–1092.
[34] B. Stadlinger, V. Hintze, S. Bierbaum, S. Moller, M.C. Schulz, R. Mai, E. Kuhlisch, S. Heinemann, D. Scharnweber, M. Schnabelrauch, U. Eckelt, Biological func- tionalization of dental implants with collagen and glycosaminoglycans-A com- parative study, J. Biomed. Mater. Res. B Appl. Biomater. 100 (2) (2012) 331–341.
[35] S. Rammelt, T. Illert, S. Bierbaum, D. Scharnweber, H. Zwipp, W. Schneiders, Coating of titanium implants with collagen, RGD peptide and chondroitin sul- fate, Biomaterials 27 (32) (2006) 5561–5571.
[36] S. Bierbaum, T. Douglas, T. Hanke, D. Scharnweber, S. Tippelt, T.K. Monsees, R.H. Funk, H. Worch, Collageneous matrix coatings on titanium implants mod- ified with decorin and chondroitin sulfate: characterization and influence on osteoblastic cells, J. Biomed. Mater. Res. A 77 (3) (2006) 551–562.
[37] P.J. Mroz, J.E. Silbert, Effects of [3H]glucosamine concentration on [3H]chondroitin sulphate formation by cultured chondrocytes, Biochem. J. 376 (Pt 2) (2003) 511–515.
[38] S. Shi, A.G. Chan, S. Mercer, G.J. Eckert, S.B. Trippel, Endogenous versus exoge- nous growth factor regulation of articular chondrocytes, J. Orthop. Res. 32 (1) (2014) 54–60.
[39] S. Mathews, S.A. Mathew, P.K. Gupta, R. Bhonde, S. Totey, Glycosaminoglycans enhance osteoblast differentiation of bone marrow derived human mesenchy- mal stem cells, J. Tissue Eng. Regen. Med. 8 (2) (2014) 143–152.
[40] B.L. Farrugia, M.S. Lord, J.M. Whitelock, J. Melrose, Harnessing chondroitin sul- phate in composite scaffolds to direct progenitor and stem cell function for tissue repair, Biomater. Sci. 6 (5) (2018) 947–957.
[41] J.C.M. Souza, M.B. Sordi, M. Kanazawa, S. Ravindran, B. Henriques, F.S. Silva, C. Aparicio, L.F. Cooper, Nano-scale modification of titanium implant surfaces to enhance osseointegration, Acta Biomater. 94 (2019) 112–131.
[42] Q. Wang, Y. Huang, Z. Qian, Nanostructured surface modification to bone im- plants for bone regeneration, J. Biomed. Nanotechnol. 14 (4) (2018) 628–648.